UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder

Expert opinion on pharmacotherapy, 2020-01, Vol.21 (1), p.9-20

2020

Volltextzugriff (PDF)

Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials

Pharmacological reports, 2020-06, Vol.72 (3), p.543-562

2020

Volltextzugriff (PDF)

A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's Perspectives

PloS one, 2015-05, Vol.10 (5), p.e0125691-e0125691

2015

Volltextzugriff (PDF)

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs

Pharmacology & therapeutics (Oxford), 2007-07, Vol.115 (1), p.116-147

2007

Volltextzugriff (PDF)

Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands

International journal of molecular sciences, 2015-08, Vol.16 (8), p.18474-18506

2015

Volltextzugriff (PDF)

Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats

Behavioural pharmacology, 2019-09, Vol.30 (6), p.471-477

2019

Volltextzugriff (PDF)

Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

PloS one, 2015-05, Vol.10 (5), p.e0124279-e0124279

2015

Volltextzugriff (PDF)

Zinc supplementation augments efficacy of imipramine in treatment resistant patients: A double blind, placebo-controlled study

Journal of affective disorders, 2009-11, Vol.118 (1), p.187-195

2009

Volltextzugriff (PDF)

Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland

PloS one, 2016-12, Vol.11 (12), p.e0168586-e0168586

2016

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland

PloS one, 2016-08, Vol.11 (8), p.e0160444-e0160444

2016

Volltextzugriff (PDF)

Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis

Archives of medical science, 2018-08, Vol.14 (5), p.1125-1136

2018

Volltextzugriff (PDF)

Mood disorders: Regulation by metabotropic glutamate receptors

Biochemical pharmacology, 2008-03, Vol.75 (5), p.997-1006

2008

Volltextzugriff (PDF)

Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessment

Pharmacology & therapeutics (Oxford), 2016-01, Vol.157, p.10-27

2016

Volltextzugriff (PDF)

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment

Frontiers in pharmacology, 2018-11, Vol.9, p.1263-1263

2018

Volltextzugriff (PDF)

Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495

Neuropharmacology, 2016-12, Vol.111, p.169-179

2016

Volltextzugriff (PDF)

Antibiotic consumption and antimicrobial resistance in Poland; findings and implications

Antimicrobial resistance & infection control, 2018-11, Vol.7 (1), p.136-136, Article 136

2018

Volltextzugriff (PDF)

Glutamatergic dysregulation in mood disorders: opportunities for the discovery of novel drug targets

Expert opinion on therapeutic targets, 2020-12, Vol.24 (12), p.1187-1209

2020

Volltextzugriff (PDF)

Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties

International journal of molecular sciences, 2023-01, Vol.24 (3), p.1981

2023

Volltextzugriff (PDF)

New 1,2,4-oxadiazole derivatives with positive mGlu4 receptor modulation activity and antipsychotic-like properties

Journal of enzyme inhibition and medicinal chemistry, 2022-12, Vol.37 (1), p.211-225

2022

Volltextzugriff (PDF)

Impact of Biologic Treatment of Crohn's Disease on the Rate of Surgeries and Other Healthcare Resources: An Analysis of a Nationwide Database From Poland

Frontiers in pharmacology, 2018-06, Vol.9, p.621-621

2018

Volltextzugriff (PDF)

The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials

Biomedicines, 2023-09, Vol.11 (10), p.2636

2023

Volltextzugriff (PDF)

The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis

Clinical rheumatology, 2013-10, Vol.32 (10), p.1415-1424

2013

Volltextzugriff (PDF)

Nowe podejście naukometryczne do oceny jakości jednostek naukowych na przykładzie Polskiej Akademii Nauk

Nauka (Wrocław, Poland), 2024-09, p.25-32

Pilc, Andrzej

2024

Volltextzugriff (PDF)

Role of mGlu receptors in psychiatric disorders – Recent advances

Pharmacology, biochemistry and behavior, 2023-11, Vol.232, p.173639-173639, Article 173639

2023

Volltextzugriff (PDF)

Activation of the mGlu7 receptor elicits antidepressant-like effects in mice

Psychopharmacologia, 2007-11, Vol.194 (4), p.555-562

2007

Volltextzugriff (PDF)

1 – 25 von 283

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(264)
Mit Volltextzugriff
(237)

Publikationsform

Sprache

Englisch
(277)
Japanisch
(24)
Polnisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(160)
Life Sciences & Biomedicine
(155)
Animals
(134)
Pharmacology & Pharmacy
(122)
Male
(105)
Rats
(75)
Neurosciences
(58)
Humans
(55)
Neurosciences & Neurology
(55)
Antidepressive Agents - Pharmacology
(50)
Mice
(45)
Rats, Wistar
(45)
Biological And Medical Sciences
(43)
Depression
(42)
Pharmacotherapy
(39)
Drug Safety And Pharmacovigilance
(38)
Pharmacy
(38)
Medical Sciences
(37)
Dose-Response Relationship, Drug
(34)
Motor Activity - Drug Effects
(34)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder

Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials

A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union's Perspectives

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs

Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands

Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats

Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Zinc supplementation augments efficacy of imipramine in treatment resistant patients: A double blind, placebo-controlled study

Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland

Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland

Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis

Mood disorders: Regulation by metabotropic glutamate receptors

Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessment

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment

Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495

Antibiotic consumption and antimicrobial resistance in Poland; findings and implications

Glutamatergic dysregulation in mood disorders: opportunities for the discovery of novel drug targets

Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties

New 1,2,4-oxadiazole derivatives with positive mGlu4 receptor modulation activity and antipsychotic-like properties

Impact of Biologic Treatment of Crohn's Disease on the Rate of Surgeries and Other Healthcare Resources: An Analysis of a Nationwide Database From Poland

The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials

The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis

Nowe podejście naukometryczne do oceny jakości jednostek naukowych na przykładzie Polskiej Akademii Nauk

Role of mGlu receptors in psychiatric disorders – Recent advances

Activation of the mGlu7 receptor elicits antidepressant-like effects in mice

Suchergebnisse filtern